Journals / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 3

An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19- positive in a pandemic center: A prospective cohort study

Pages
554–564
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nevertheless, there is a need for further, randomized controlled studies on this subject with the inclusion of greater numbers of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Convalescent plasma (CP) might be an additional treatment modality in COVID-19.
📊
Key Findings & Data:The aim of this study was to compare CP-related clinical characteristics and perinatal outcomes in pregnant women with mild or moderate-severe COVID-19.
💡
Conclusion & Impact:Nevertheless, there is a need for further, randomized controlled studies on this subject with the inclusion of greater numbers of patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Convalescent plasma (CP) might be an additional treatment modality in COVID-19. The aim of this study was to compare CP-related clinical characteristics and perinatal outcomes in pregnant women with mild or moderate-severe COVID-19. Materials and methods: This prospective cohort study included 36 pregnant women (12 mild and 24 moderate-severe), who underwent CP therapy. The CP obtained from recently recovered donors was transfused to patients together with maximum supportive care and antiviral agents. The groups were then compared in respect of clinical characteristics, laboratory parameters, obstetric complications, and neonatal outcomes. Results: Significant differences were determined between the groups in respect of systemic corticosteroids in COVID-19 treatment (41.7%, 87.5%, p = 0.004), oxygen (O2) support (0%, 91.7%, p < 0.001), chest imaging (41.7%, 58.3%, p = 0.02), intensive care unit admission (0%, 20.8%, p = 0.03) and length of hospitalization (5.5 versus 9.5 days, p < 0.001). The O2 saturation levels before and after administration of CP were significantly lower in the moderate-severe COVID-19 group (p < 0.05). The O2 therapy time before and after administration of CP and total O2 therapy time were significantly lower in the mild COVID-19 group (p < 0.05). Platelet, plateletcrit and lymphocyte counts were significantly higher in both the mild and moderate-severe COVID-19 groups after treatment compared to the pretreatment values (p < 0.05). Conclusion: Although data on the results of CP treatment in pregnant women are somewhat limited, it has been suggested that early CP treatment may be associated with improvements in laboratory and ventilatory parameters in pregnant women with mild and moderatesevere COVID-19. Nevertheless, there is a need for further, randomized controlled studies on this subject with the inclusion of greater numbers of patients.

🔖

Cite This Article

ERDEN, A., TEKİN, Ö. M., TANAÇAN, A., OMMA, A., EROL, S. A., ÜNLÜ, S., APAYDIN, H., HENDEM, D. U., KÜÇÜKŞAHİN, O., ATEŞ, İ., ŞAHİN, D., AYHAN, Ş. G., OLUKLU, D. (2022). An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19- positive in a pandemic center: A prospective cohort study. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 3, 554–564. https://ajindex.com/articles/609259

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Chen N, Zhou M, Dong X, Qu J, Gong F et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020
  2. 395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7 2. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Bioscience Trends. 2020
  3. 14(1):69-71. doi:10.5582/bst.2020.01020 3. Clark E, Guilpain P, Filip IL, Pansu N, Bihan CL et al. Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery. British Journal of Haematology. 2020
  4. 190(3):e154-e156. doi:10.1111/bjh.16981 4. Ciftciler R, Ciftciler AE. Treatment modalities in COVID 19. Aksaray University Journal of Medical Sciences. 2021
  5. 2(1): 20- 21. 5. Magallanes-Garza GI, Valdez-Alatorre C, Dávila-González D, Martínez-Reséndez MF, Sánchez-Salazar SS et al. Rapid improvement of a critically ill obstetric patient with SARSCoV-2 infection after administration of convalescent plasma. International Journal of Gynaecology and Obstetrics. 2021
  6. 152(3):439-441. doi:10.1002/ijgo.13467 6. Soleimani Z, Soleimani A. ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids [published online ahead of print, 2020 Jul 26]. The Journal of Maternal-Fetal and Neonatal Medicine. 2020
  7. doi:10.1080/14767058.2020.1797669 7. Anderson J, Schauer J, Bryant S, Graves CR. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report. Case Reports in Women’s Health. 2020
  8. e00221. doi:10.1016/j.crwh.2020. e00221 8. Sahin D, Tanacan A, Erol SA, Anuk AT, Eyi EGY et al. A pandemic center’s experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study. International Journal of Gynaecology and Obstetrics. 2020
  9. 151(1):74-82. doi:10.1002/ijgo.13318 9. Sahin D, Tanacan A, Erol SA, Anuk AT, Yetiskin FDY et al. Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: A prospective cohort study from Turkey. International Journal of Gynaecology and Obstetrics. 2021
  10. 152(3):328-334. doi:10.1002/ijgo.13460 10. Tanacan A, Erol SA, Turgay B, Anuk AT, Secen EI et al. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey. European Journal of Obstetrics Gynecology and R